liraglutide glp 1 First Generic of Once-Daily GLP-1 Injection Approved for Diabetes Liraglutide vs Semaglutide vs GLP-1

A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result

This combination therapy has been shown to lead to an extra 1.37 kg of weight loss , a 0.88 kg/m decrease in BMI , and a 2.46 cm reduction in waist circumference compared to metformin by itself

We confirmed that exendin-4 residence time is increased by BETP, without changes in the association rate (Fig

A modest improvement in appetite regulation and metabolic function could be meaningful for someone who does not need or want prescription medication